$138.53
2.90%
Nasdaq, Jan 02, 10:00 pm CET

ICU Medical, Inc. Stock price

$138.53
-8.13 5.54% 1M
+2.35 1.73% 6M
-4.14 2.90% YTD
-19.45 12.31% 1Y
-18.95 12.03% 3Y
-73.53 34.67% 5Y
+33.37 31.73% 10Y
+99.32 253.30% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-4.14 2.90%

Key metrics

Basic
Market capitalization
$3.4b
Enterprise Value
$4.4b
Net debt
$1.0b
Cash
$299.7m
Shares outstanding
24.7m
Valuation (TTM | estimate)
P/E
negative | 18.0
P/S
1.5 | 1.5
EV/Sales
1.9 | 2.0
EV/FCF
71.3
P/B
1.6
Financial Health
Equity Ratio
46.8%
Return on Equity
-6.0%
ROCE
3.6%
ROIC
-1.1%
Debt/Equity
0.6
Financials (TTM | estimate)
Revenue
$2.3b | $2.3b
EBITDA
$132.5m | $408.5m
EBIT
$130.7m | $296.6m
Net Income
$-7.4m | $190.3m
Free Cash Flow
$62.2m
Growth (TTM | estimate)
Revenue
-0.8% | -5.2%
EBITDA
140.7% | 293.0%
EBIT
142.5% | 188.6%
Net Income
93.4% | 261.7%
Free Cash Flow
-61.0%
Margin (TTM | estimate)
Gross
36.5%
EBITDA
5.7% | 18.1%
EBIT
5.6%
Net
-0.3% | 8.4%
Free Cash Flow
2.7%
More
EPS
$-0.3
FCF per Share
$2.5
Short interest
6.3%
Employees
15k
Rev per Employee
$160.0k
Show more

Is ICU Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

ICU Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a ICU Medical, Inc. forecast:

10x Buy
83%
2x Hold
17%

Analyst Opinions

12 Analysts have issued a ICU Medical, Inc. forecast:

Buy
83%
Hold
17%

Financial data from ICU Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,320 2,320
1% 1%
100%
- Direct Costs 1,474 1,474
6% 6%
64%
846 846
10% 10%
36%
- Selling and Administrative Expenses 627 627
1% 1%
27%
- Research and Development Expense 89 89
0% 0%
4%
132 132
141% 141%
6%
- Depreciation and Amortization 1.74 1.74
54% 54%
0%
EBIT (Operating Income) EBIT 131 131
143% 143%
6%
Net Profit -7.36 -7.36
93% 93%
0%

In millions USD.

Don't miss a Thing! We will send you all news about ICU Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICU Medical, Inc. Stock News

Neutral
GlobeNewsWire
5 days ago
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P.
Positive
Seeking Alpha
5 days ago
ICU Medical has emerged from a painful post-Smiths Medical integration process, shifting focus from remediation to growth and margin expansion. Essentially divesting the low-margin IV solutions business to Otsuka and launching new products can drive gross margin improvement toward 43%-45%. ICUI should achieve sustained EBITDA margins above 20% and double-digit FCF growth, supporting deleveragin...
Neutral
GlobeNewsWire
about 2 months ago
SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in New York, December 2-4, 2025. ICU Medical's fireside chat will be on Thursday, D...
More ICU Medical, Inc. News

Company Profile

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Head office United States
CEO Vivek Jain
Employees 15,000
Founded 1984
Website www.icumed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today